Account
Enormous adds Reliance Health Insurance to its portfolio
MUMBAI: Enormous Brands has announced that it has won the creative mandate of Reliance Health Insurance. The agency bagged the business post after a multi-agency pitch and will handle it from its Mumbai office.
Enormous Brands managing partner Ashish Khazanchi said, “Reliance is changing the basic framework of the health insurance business with their genuinely innovative products. It is very important to capture this disruption in the ensuing brand communication and strategic framework. I believe that we understand the business and the emotion behind it well, and I look forward to beginning this journey of innovative work for Reliance Health Insurance.”
Speaking about partnering with Enormous, Reliance Health Insurance chief executive officer Ravi Vishwanath said, “We are working towards a better way to do health insurance and we needed a partner who shared our values. Enormous do share our values and we look forward to an exciting partnership.”
A new launch campaign for the brand is already underway and will be seen across several mediums including television, print, digital and outdoor.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
